Viewing Study NCT01974258


Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2025-12-25 @ 10:03 PM
Study NCT ID: NCT01974258
Status: WITHDRAWN
Last Update Posted: 2016-11-02
First Post: 2013-10-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patients
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module